Upstream Bio Ratios (2023-2026) | UPB

1Y3Y5Y7Y10YAll
Download Data
Ratios Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
Gross Margin (Quarter) 45.16%-177.65%-258.98%-350.24%-276.15%-967.24%-272.18%-1,148.80%-380.95%
EBT Margin (Quarter) -1,265.54%-2,846.89%-2,147.97%-2,875.10%-2,634.10%-3,465.25%-4,818.02%-4,259.98%-4,938.36%-6,364.22%-3,922.73%
EBIT Margin (Quarter) -1,511.43%-3,184.44%-2,345.78%-3,439.22%-3,112.52%-4,293.31%-5,656.01%-4,732.87%-5,539.39%-6,911.23%-4,218.09%
EBITDA Margin (Quarter) -1,511.43%-3,184.44%-2,345.78%-3,439.22%-3,112.52%-4,293.31%-5,656.01%-4,732.87%-5,539.39%-6,911.23%-4,218.09%
Operating Margin (Quarter) -1,511.43%-3,184.44%-2,345.78%-3,439.22%-3,112.52%-4,293.31%-5,656.01%-4,732.87%-5,539.39%-6,911.23%-4,218.09%
Net Margin (Quarter) -1,006.92%-3,329.78%-2,189.06%-3,835.69%-3,465.07%-3,554.65%-4,818.02%-4,265.31%-4,941.14%-6,356.14%-3,922.73%
FCF Margin (Quarter) -3,580.00%-2,744.06%-1,575.69%-2,300.16%-3,261.01%-7,272.97%-4,187.73%-3,257.39%-4,601.95%-4,627.85%
Efficiency
Assets Average (Quarter) 357.21M468.94M438.35M405.86M372.48M335.91M
Equity Average (Quarter) -117.67M-128.27M-140.01M-153.46M154.77M457.73M427.18M393.66M359.18M321.88M
Invested Capital (Quarter) -112.20M-123.13M-133.41M-146.61M-160.31M469.85M445.61M408.74M378.58M339.77M304.00M
Asset Utilization Ratio (Quarter) 0.010.000.010.010.010.01
Leverage & Solvency
Equity Ratio (Quarter) -1.05-0.690.980.980.970.970.960.96
Valuation
Enterprise Value (Quarter) -47.32M-109.81M-31.51M-47.34M-220.66M-465.56M-431.38M-393.58M-372.43M-341.51M-294.58M
Return Ratios
Return on Sales (Quarter) -0.13%-0.28%-0.21%-0.29%-0.26%-0.35%-0.48%-0.43%-0.49%-0.64%-0.39%
Return on Capital Employed (Quarter) -22.44%-20.63%-28.44%-35.67%-44.66%-53.36%
Return on Assets (Quarter) 0.00%0.00%0.00%0.00%0.00%0.00%
Return on Equity (Quarter) 0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%